amyloid P component, serum ; Mus musculus






90 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 500121 Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology 1979 Jul 6
2 2361734 IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP). Inflammation 1990 Jun 2
3 2436816 Regulation of the antibody response by the acute phase reactant: mouse serum amyloid P-component (SAP). Cell Immunol 1987 May 2
4 2459289 The heme moiety of cytochrome c is an autoreactive Ir gene-restricted T cell epitope. J Exp Med 1988 Sep 1 1
5 2809211 Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. J Immunol 1989 Nov 1 4
6 3086231 Serum amyloid P-component-induced enhancement of macrophage listericidal activity. Infect Immun 1986 Jun 4
7 3092598 Studies on type II collagen induced arthritis in mice. Agents Actions 1986 Jun 1
8 3142488 Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum 1988 Nov 3
9 3143483 Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component (SAP) to macrophages. Cell Immunol 1988 Dec 14
10 3189043 The effect of danazol in the MRL/lpr mouse model of autoimmune disease. Agents Actions 1988 Aug 5
11 3351437 Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J Exp Med 1988 Mar 1 1
12 3525679 Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component. J Immunol Methods 1986 Jul 24 4
13 3568456 Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Clin Exp Immunol 1986 Dec 2
14 3689465 Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component. Arthritis Rheum 1987 Nov 2
15 3882285 Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse. Clin Exp Immunol 1985 Jan 3
16 6600258 Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol 1983 Feb 2
17 6704197 Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures. Arthritis Rheum 1984 Mar 1
18 6806378 Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J Immunol 1982 Aug 2
19 7389204 Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Clin Exp Immunol 1980 Feb 1
20 7513450 Induction of hepatic acute-phase protein transcripts: differential effects of acute and subchronic dimethylnitrosamine exposure in vivo. Toxicol Appl Pharmacol 1994 Apr 2
21 7929814 The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 1994 Oct 1
22 8202534 Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A 1994 Jun 7 1
23 8999915 Characterization of the binding of serum amyloid P to laminin. J Biol Chem 1997 Jan 24 1
24 9144481 Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells. J Immunol 1997 May 15 1
25 9558086 Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting. J Immunol 1998 Apr 15 3
26 10338482 Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. Infect Immun 1999 Jun 1
27 10371509 Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999 Jun 2
28 10450530 Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Int J Vitam Nutr Res 1999 Jul 2
29 10754317 Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 2000 Apr 15 1
30 11121061 Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci U S A 2000 Dec 19 1
31 11145702 Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J Immunol 2001 Jan 15 2
32 11169219 Serum amyloid P-component-induced colony-stimulating factors production by macrophages. Scand J Immunol 2001 Feb 5
33 11207541 CpG-DNA upregulates the major acute-phase proteins SAA and SAP. Cell Microbiol 1999 Jul 3
34 12163630 Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. J Nucl Med 2002 Aug 2
35 12444113 Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002 Dec 1 1
36 12682764 [Effect of topical dexamethasone treatment on antigen-presenting cells in murine corneas]. Ophthalmologe 2003 Apr 1
37 12960324 In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival. J Immunol 2003 Sep 15 2
38 14527932 Environmental oxygen tension affects phenotype in cultured bone marrow-derived macrophages. Am J Physiol Lung Cell Mol Physiol 2004 Feb 1
39 14615049 Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice. Neurosci Lett 2003 Nov 27 1
40 14764719 Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J Immunol 2004 Feb 15 1
41 15140051 Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro. Scand J Immunol 2004 May 3
42 15240692 Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 2004 Jul 15 3
43 15467373 The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 2004 Nov 1
44 16194869 Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis. Amyloid 2005 Sep 1
45 16298151 Serum amyloid P-component in murine tuberculosis: induction kinetics and intramacrophage Mycobacterium tuberculosis growth inhibition in vitro. Microbes Infect 2006 Feb 3
46 16394003 Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice. J Immunol 2006 Jan 15 1
47 16517713 Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide. J Immunol 2006 Mar 15 1
48 16543948 Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 2006 Apr 1
49 17312129 Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol 2007 Mar 1 2
50 17312143 Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 2007 Mar 1 1